TY - JOUR
T1 - A single-step “breeding” generated a diagnostic anti-cortisol antibody fragment with over 30-fold enhanced affinity
AU - Oyama, Hiroyuki
AU - Morita, Izumi
AU - Kiguchi, Yuki
AU - Morishita, Tomomi
AU - Fukushima, Sakiko
AU - Nishimori, Yuki
AU - Niwa, Toshifumi
AU - Kobayashi, Norihiro
N1 - Funding Information:
Acknowledgments This work was supported in part by Grants from the Japan Society for the Promotion of Science (JSPS) (JSPS KAKENHI Grant Number JP16K08954) and the Science Research Promotion Fund of the Japan Private School Promotion Foundation. We would like to thank Dr. Eskil Söderlind (Avena Partners AB, Sweden) and Professor Carl A. K. Borrebaeck (Lund University, Sweden) for providing the pEXmide 5 vector and allowing us to modify it to generate pEXmide 7 and pEXmide 7 vectors.
Funding Information:
Acknowledgments This work was supported in part by Grants from the Japan Society for the Promotion of Science (JSPS) (JSPS KAKENHI Grant Number JP16K08954) and the Science Research Promotion Fund of the Japan Private School Promotion Foundation. We would like to thank Dr. Eskil Söderlind (Avena Partners AB, Sweden) and Professor Carl A. K. Borrebaeck (Lund University, Sweden) for providing the pEXmide 5 vector and allowing us to modify it to generate pEXmide 7 and pEXmide 7′ vectors.
Publisher Copyright:
© 2017 The Pharmaceutical Society of Japan.
PY - 2017
Y1 - 2017
N2 - Cortisol levels in bodily fluids represent a useful index for pituitary−adrenal function, and thus practical anti-cortisol antibodies are required. We have studied “antibody-breeding” approaches, which involve in vitro evolution of antibodies to improve their antigen-binding performances. Here, we produced an antibody fragment to measure serum cortisol levels with over 30-fold enhanced affinity after single mutagenesis and selection steps. A mouse anti-cortisol antibody, Ab-CS#3, with insufficient affinity for practical use, was chosen as the prototype antibody. A “wild-type” single-chain Fv fragment (wt-scFv; Ka, 3.4×108 M−1) was prepared by bacterial expression of a fusion gene combining the VH and VL genes for this antibody. Then, random point mutations were generated separately in VH or VL by error-prone PCR, and the resulting products were used to assemble scFv genes, which were displayed on filamentous phages. Repeated panning of the phage library identified a mutant scFv (scFv#m1-L10) with an over 30-fold enhanced affinity (Ka 1.2×1010 M−1). Three amino acid substitutions (Cys49Ser, Leu54Pro, and Ser63Gly) were observed in its VL sequence. In a competitive enzyme-linked immunosorbent assay (ELISA), the mutant scFv generated dose–response curves with measuring range ca. 0.03–0.6 ng/assay cortisol, midpoint of which (0.15 ng/assay) was 7.3-fold lower than that of wt-scFv. Although cortisone, 11-deoxycortisol, and prednisolone showed considerable cross-reactivity, the mutant scFv should enable sensitive routine cortisol assays, except for measurement after metyrapone or high-dose of prednisolone administrations. Actually, cortisol levels of control sera obtained with the scFv-based ELISA were in the reference range.
AB - Cortisol levels in bodily fluids represent a useful index for pituitary−adrenal function, and thus practical anti-cortisol antibodies are required. We have studied “antibody-breeding” approaches, which involve in vitro evolution of antibodies to improve their antigen-binding performances. Here, we produced an antibody fragment to measure serum cortisol levels with over 30-fold enhanced affinity after single mutagenesis and selection steps. A mouse anti-cortisol antibody, Ab-CS#3, with insufficient affinity for practical use, was chosen as the prototype antibody. A “wild-type” single-chain Fv fragment (wt-scFv; Ka, 3.4×108 M−1) was prepared by bacterial expression of a fusion gene combining the VH and VL genes for this antibody. Then, random point mutations were generated separately in VH or VL by error-prone PCR, and the resulting products were used to assemble scFv genes, which were displayed on filamentous phages. Repeated panning of the phage library identified a mutant scFv (scFv#m1-L10) with an over 30-fold enhanced affinity (Ka 1.2×1010 M−1). Three amino acid substitutions (Cys49Ser, Leu54Pro, and Ser63Gly) were observed in its VL sequence. In a competitive enzyme-linked immunosorbent assay (ELISA), the mutant scFv generated dose–response curves with measuring range ca. 0.03–0.6 ng/assay cortisol, midpoint of which (0.15 ng/assay) was 7.3-fold lower than that of wt-scFv. Although cortisone, 11-deoxycortisol, and prednisolone showed considerable cross-reactivity, the mutant scFv should enable sensitive routine cortisol assays, except for measurement after metyrapone or high-dose of prednisolone administrations. Actually, cortisol levels of control sera obtained with the scFv-based ELISA were in the reference range.
KW - Affinity maturation
KW - Antibody
KW - Cortisol
KW - Enzyme-linked immunosorbent assay
KW - In vitro evolution
KW - Single-chain Fv fragment
UR - http://www.scopus.com/inward/record.url?scp=85035762489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85035762489&partnerID=8YFLogxK
U2 - 10.1248/bpb.b17-00633
DO - 10.1248/bpb.b17-00633
M3 - Article
C2 - 29199242
AN - SCOPUS:85035762489
SN - 0918-6158
VL - 40
SP - 2191
EP - 2198
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 12
ER -